跳至主要内容
临床试验/JPRN-UMIN000017789
JPRN-UMIN000017789已完成未知

Impact of primary prevention and chemoprevention on the promotion of prostate cancer and the risk of developing clinically manifested prostate cancer: A prospective cohort study - A Cohort study investigating the impact of primary prevention on the development of prostate cancer

The Japanese Foundation for Prostate Research0 个研究点目标入组 887 人开始时间: 2015年6月10日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
887

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
35years-old 至 54years-old(—)
性别
Male

入选标准

  • 未提供

排除标准

  • 1) having past or present history of prostate cancer 2) having severe complications (caridiac disease, interstitial pneumonia, bleeding tendency, uncontrollable hypertension, diabetes mellitus, etc.) 3) having uncontrolled other malignant disease (excluding carcinoma in situ, skin cancer and no evidence of recurrence more than 3 years after the treatment) 4) having any inappropriate factor judged by investigators

研究者

发起方
The Japanese Foundation for Prostate Research

相似试验